Comparison timestamp: 2025-05-05 13:36:34 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-c.htm
Live cdc.gov URL ↗: https://www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-c.htm
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-c.htm
Live cdc.gov URL ↗: https://www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-c.htm
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected:
Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-c.htm | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.[More]About Us Report Bug Compare ContentSkip directly to site content Skip directly to searchEspañol | Other LanguagesHere's how you knowAn official website of the United States government Here's how you knowViral HepatitisViral HepatitisCenters for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People Viral HepatitisSearchSearch Menu Navigation MenuSubmitViral Hepatitis* 2022 Surveillance+ BACK2022 Surveillance+ Overviewo BACKOverviewo BACK2022 Surveillance Overviewo Backgroundo National Profile of Viral Hepatitiso Technical Noteso Viral Hepatitis Home+ Hepatitis Ao BACKHepatitis Ao BACK2022 Surveillance Hepatitis Ao Figure 1.1 – Number of Cases & Estimated Infectionso Figure 1.2 – Case Rates by Jurisdictiono Figure 1.3 – Map of Case Rateso Figure 1.4 – Case Rates by Age Groupo Figure 1.5 – Case Rates by Sexo Figure 1.6 – Case Rates by Race & Ethnicityo Figure 1.7 – Infection Risk Behaviorso Table 1.1 – Number & Rates of Cases by Jurisdictiono Table 1.2 – Cases & Rates by Demographicso Table 1.3 – Cases by Risk Behaviorso Table 1.4 – Death Rates by Demographicso Viral Hepatitis Home+ Hepatitis Bo BACKHepatitis Bo BACK2022 Surveillance Hepatitis Bo Figure 2.1 – Acute – Number of Caseso Figure 2.2 – Acute – Case Rates by Jurisdictiono Figure 2.3 – Acute – Map of Case Rateso Figure 2.4 – Acute – Case Rates by Age Groupo Figure 2.5 – Acute – Case Rates by Sexo Figure 2.6 – Acute – Case Rates by Race & Ethnicityo Figure 2.7 – Acute – Infection Risko Figure 2.8 – Map of Death Rateso Table 2.1 – Acute – Number & Rates of Caseso Table 2.2 – Acute – Cases & Rates by Demographicso Table 2.3 – Acute – Cases by Risk Behaviorso Table 2.4 – Perinatal – Cases by Jurisdictiono Table 2.5 – Chronic – Case Rates by Jurisdictiono Table 2.6 – Chronic – Case Rates by Demographicso Table 2.7 – Death Rates by Jurisdictiono Table 2.8 – Death Rates by Demographicso Viral Hepatitis Home+ Hepatitis Co BACKHepatitis Co BACK2022 Surveillance Hepatitis Co Figure 3.1 – Acute – Number of Caseso Figure 3.2 – Acute – Case Rates by Jurisdictiono Figure 3.3 – Acute – Map of Case Rateso Figure 3.4 – Acute – Case Rates by Age Groupo Figure 3.5 – Acute – Case Rates by Sexo Figure 3.6 – Acute – Case Rates by Race & Ethnicityo Figure 3.7 – Acute – Infection Risk Behaviorso Figure 3.8 – Chronic – Case Rates by Sex & Ageo Figure 3.9 – Map of Death Rateso Table 3.1 – Acute – Number & Rates of Caseso Table 3.2 – Acute – Cases & Rates by Demographicso Table 3.3 – Acute – Infection Risk Behaviorso Table 3.4 – Perinatal – Cases by Jurisdictiono Table 3.5 – Chronic – Case Rates by Jurisdictiono Table 3.6 – Chronic – Case Rates by Demographicso Table 3.7 – Death Rates by Jurisdictiono Table 3.8 – Death Rates by Demographicso Viral Hepatitis Home+ Perinatal Hepatitis B Prevention Programo BACKPerinatal Hepatitis B Prevention Programo BACK2022 Surveillance Perinatal Hepatitis B Prevention Programo Figure 4.1 – Outcomes by Birth Cohort Yearo Table 4.1 – Outcomes by Jurisdictiono Viral Hepatitis Home+ Appendixo BACKAppendixo BACK2022 Surveillance Appendixo Figure 5.1 – Reported Acute Hepatitis B & C Caseso Table 5.1 – Acute Viral Hepatitis Caseso Table 5.2 – Acute & Chronic Hepatitis C Caseso Table 5.3 – Numbers & Rates of Reported Acute Hepatitis B & Co Figures & Tables – 2022 Viral Hepatitis Surveillance Reporto Viral Hepatitis Home+ Viral Hepatitis Home* 2021 Surveillance+ BACK2021 Surveillance+ Overviewo BACKOverviewo BACK2021 Surveillance Overviewo Backgroundo National Profile of Viral Hepatitiso Technical Noteso Viral Hepatitis Home+ Hepatitis Ao BACKHepatitis Ao BACK2021 Surveillance Hepatitis Ao Figure 1.1 – Number of Cases & Estimated Infectionso Figure 1.2 – Case Rates by Jurisdictiono Figure 1.3 – Map of Case Rateso Figure 1.4 – Case Rates by Age Groupo Figure 1.5 – Case Rates by Sexo Figure 1.6 – Case Rates by Race/Ethnicityo Figure 1.7 – Risk & Exposure Datao Table 1.1 – Number & Rates of Cases by Jurisdictiono Table 1.2 – Cases & Rates by Demographicso Table 1.3 – Risk & Exposure Datao Table 1.4 – Death Rates by Demographicso Viral Hepatitis Home+ Hepatitis Bo BACKHepatitis Bo BACK2021 Surveillance Hepatitis Bo Figure 2.1 – Acute – Number of Cases & Estimated Infectionso Figure 2.2 – Acute – Case Rates by Jurisdictiono Figure 2.3 – Acute – Map of Case Rateso Figure 2.4 – Acute – Case Rates by Age Groupo Figure 2.5 – Acute – Case Rates by Sexo Figure 2.6 – Acute – Case Rates by Race/Ethnicityo Figure 2.7 – Acute – Risk & Exposureo Figure 2.8 – Map of Death Rateso Table 2.1 – Acute – Numbers & Rates of Caseso Table 2.2 – Acute – Cases & Rates by Demographicso Table 2.3 – Acute – Risk & Exposure Datao Table 2.4 – Perinatal – Cases by Jurisdictiono Table 2.5 – Chronic – Case Rates by Jurisdictiono Table 2.6 – Chronic – Case Rates by Demographicso Table 2.7 – Death Rates by Jurisdictiono Table 2.8 – Death Rates by Demographicso Viral Hepatitis Home+ Hepatitis Co BACKHepatitis Co BACK2021 Surveillance Hepatitis Co Figure 3.1 – Acute – Number of Cases & Estimated Infectionso Figure 3.2 – Acute – Case Rates by Jurisdictiono Figure 3.3 – Acute – Map of Case Rateso Figure 3.4 – Acute – Case Rates by Age Groupo Figure 3.5 – Acute – Case Rates by Sexo Figure 3.6 – Acute – Case Rates by Race/Ethnicityo Figure 3.7 – Acute – Risk & Exposure Datao Figure 3.8 – Chronic – Case Rates by Sex & Ageo Figure 3.9 – Map of Death Rateso Table 3.1 – Acute – Number & Rates of Caseso Table 3.2 – Acute – Cases & Rates by Demographicso Table 3.3 – Acute – Risk & Exposure Datao Table 3.4 – Perinatal – Cases by Jurisdictiono Table 3.5 – Chronic – Case Rates by Jurisdictiono Table 3.6 – Chronic – Case Rates by Demographicso Table 3.7 – Death Rates by Jurisdictiono Table 3.8 – Death Rates by Demographicso Viral Hepatitis Home+ Perinatal Hepatitis B Prevention Programo BACKPerinatal Hepatitis B Prevention Programo BACK2021 Surveillance Perinatal Hepatitis B Prevention Programo Figure 4.1 – Outcomes by Birth Cohort Yearo Table 4.1 – Outcomes by Jurisdictiono Viral Hepatitis Home+ Appendixo BACKAppendixo BACK2021 Surveillance Appendixo Figure 5.1 – Number of Cases & Estimated Infections for 18–40 Yearso Table 5.1 – Reported Cases & Estimated Infections – 95% CIo Table 5.2 – Acute & Chronic Hepatitis C Cases Confirmed and Probableo Table 5.3 – Hepatitis B & C for 18–40 Yearso Tables & Figures – 2021 Viral Hepatitis Surveillance Reporto Viral Hepatitis Home+ Viral Hepatitis Home* 2020 Surveillance+ BACK2020 Surveillance+ Overviewo BACKOverviewo BACK2020 Surveillance Overviewo Backgroundo National Profile of Viral Hepatitiso Technical Noteso Viral Hepatitis Home+ Hepatitis Ao BACKHepatitis Ao BACK2020 Surveillance Hepatitis Ao Figure 1.1 – Number of Cases & Estimated Infectionso Figure 1.2 – Case Rates by Jurisdictiono Figure 1.3 – Map of Case Rateso Figure 1.4 – Case Rates by Age Groupo Figure 1.5 – Case Rates by Sexo Figure 1.6 – Case Rates by Race & Ethnicityo Figure 1.7 – Risk & Exposure Datao Table 1.1 – Number & Rates of Cases by Jurisdictiono Table 1.2 – Cases & Rates by Demographicso Table 1.3 – Risk & Exposure Datao Table 1.4 – Death Rates by Demographicso Viral Hepatitis Home+ Hepatitis Bo BACKHepatitis Bo BACK2020 Surveillance Hepatitis Bo Figure 2.1 – Acute – Number of Cases & Estimated Infectionso Figure 2.2 – Acute – Case Rates by Jurisdictiono Figure 2.3 – Acute – Map of Case Rateso Figure 2.4 – Acute – Case Rates by Age Groupo Figure 2.5 – Acute – Case Rates by Sexo Figure 2.6 – Acute – Case Rates by Race & Ethnicityo Figure 2.7 – Acute – Risk & Exposureo Figure 2.8 – Map of Death Rateso Table 2.1 – Acute – Number & Rates of Caseso Table 2.2 – Acute – Cases & Rates by Demographicso Table 2.3 – Acute – Risk & Exposure Datao Table 2.4 – Perinatal – Cases by Jurisdictiono Table 2.5 – Chronic – Case Rates by Jurisdictiono Table 2.6 – Chronic – Case Rates by Demographicso Table 2.7 – Death Rates by Jurisdictiono Table 2.8 – Death Rates by Demographicso Viral Hepatitis Home+ Hepatitis Co BACKHepatitis Co BACK2020 Surveillance Hepatitis Co Figure 3.1 – Acute – Number of Cases & Estimated Infectionso Figure 3.2 – Acute – Case Rates by Jurisdictiono Figure 3.3 – Acute – Map of Case Rateso Figure 3.4 – Acute – Case Rates by Age Groupo Figure 3.5 – Acute – Case Rates by Sexo Figure 3.6 – Acute – Case Rates by Race & Ethnicityo Figure 3.7 – Acute – Risk & Exposure Datao Figure 3.8 – Chronic – Case Rates by Sex & Ageo Figure 3.9 – Map of Death Rateso Table 3.1 – Acute – Number & Rates of Caseso Table 3.2 – Acute – Cases & Rates by Demographicso Table 3.3 – Acute – Risk & Exposure Datao Table 3.4 – Perinatal – Cases by Jurisdictiono Table 3.5 – Chronic – Case Rates by Jurisdictiono Table 3.6 – Chronic – Case Rates by Demographicso Table 3.7 – Death Rates by Jurisdictiono Table 3.8 – Death Rates by Demographicso Viral Hepatitis Home+ Perinatal Hepatitis B Prevention Programo BACKPerinatal Hepatitis B Prevention Programo BACK2020 Surveillance Perinatal Hepatitis B Prevention Programo Figure 4.1 – Outcomes by Birth Cohort Yearo Table 4.1 – Outcomes by Jurisdictiono Viral Hepatitis Home+ Appendixo BACKAppendixo BACK2020 Surveillance Appendixo Figure 5.1 – Hepatitis B & C Rates 18-40 yearso Table 5.1 – Estimated infections and 95% CIo Table 5.2 – Acute & Chronic Hepatitis C Cases Confirmed and Probableo Table 5.3 – Hepatitis B & C Rates 18-40 yearso Tables & Figures | 2020 Viral Hepatitis Surveillance Reporto Viral Hepatitis Home+ Viral Hepatitis Home* 2019 Surveillance+ BACK2019 Surveillance+ Introduction+ Hepatitis Ao BACKHepatitis Ao BACK2019 Surveillance Hepatitis Ao Figure 1.1o Figure 1.2o Figure 1.3o Figure 1.4o Figure 1.5o Figure 1.6o Figure 1.7o Table 1.1o Table 1.2o Table 1.3o Table 1.4o Viral Hepatitis Home+ Hepatitis Bo BACKHepatitis Bo BACK2019 Surveillance Hepatitis Bo Figure 2.1o Figure 2.2o Figure 2.3o Figure 2.4o Figure 2.5o Figure 2.6o Figure 2.7o Figure 2.8o Table 2.1o Table 2.2o Table 2.3o Table 2.4o Table 2.5o Table 2.6o Table 2.7o Table 2.8o Viral Hepatitis Home+ Hepatitis Co BACKHepatitis Co BACK2019 Surveillance Hepatitis Co Figure 3.1o Figure 3.2o Figure 3.3o Figure 3.4o Figure 3.5o Figure 3.6o Figure 3.7o Figure 3.8o Figure 3.9o Table 3.1o Table 3.2o Table 3.3o Table 3.4o Table 3.5o Table 3.6o Table 3.7o Table 3.8o Viral Hepatitis Home+ Appendix+ Supplemental Report+ Viral Hepatitis Home* 2018 Surveillance+ BACK2018 Surveillance+ Introduction+ Hepatitis A+ Hepatitis B+ Hepatitis C+ Appendix+ Viral Hepatitis Home* 2017 Surveillance+ BACK2017 Surveillance+ Hepatitis A Tables and Figures+ Hepatitis B Tables and Figures+ Hepatitis C Tables and Figures+ Viral Hepatitis Home* 2016 Surveillance+ BACK2016 Surveillance+ Commentary+ Table 1.1 Hepatitis C Outbreaks+ Viral Hepatitis Home* 2015 Surveillance+ BACK2015 Surveillance+ Commentary+ Table 1.1 Hepatitis C Outbreaks+ Viral Hepatitis Home* 2014 Surveillance+ BACK2014 Surveillance+ Commentary+ Viral Hepatitis Home* 2013 Surveillance+ BACK2013 Surveillance+ Commentaryo BACKCommentaryo BACK2013 Surveillance Commentaryo Erratumo Viral Hepatitis Home+ Viral Hepatitis Home* 2012 Surveillance+ BACK2012 Surveillance+ Commentary+ Viral Hepatitis Home* 2011 Surveillance+ BACK2011 Surveillance+ Commentary+ Viral Hepatitis Home* 2010 Surveillance+ BACK2010 Surveillance+ Commentary+ Viral Hepatitis Home* 2009 Surveillance+ BACK2009 Surveillance+ Commentary+ Viral Hepatitis Home* 2008 Surveillance+ BACK2008 Surveillance+ Commentary+ Viral Hepatitis Home* Viral Hepatitis HomeViral HepatitisViral Hepatitis HomeHepatitis C Surveillance 2021Hepatitis CWhat Is Hepatitis CHepatitis C is a liver disease caused by the hepatitis C virus (HCV). HCV is a bloodborne virus. Transmission can happen through sharing needles, syringes, or other drug-injection equipment; from the gestational parent to baby during pregnancy or at birth; or rarely through sexual contact.On this page* What is Hepatitis C?* Hepatitis C in 2021* Acute Hepatitis C* Chronic Hepatitis C* Hepatitis C Figures & TablesToday, in the United States, the majority of persons become infected with HCV by sharing needles or other equipment used to inject drugs. For certain persons, hepatitis C is a short-term illness, but for more than half of persons who become infected with HCV, it becomes a long-term, chronic infection.Like chronic hepatitis B, chronic hepatitis C is a serious disease that can result in cirrhosis, liver cancer, and death. Persons might not be aware of their infection because they do not have symptoms.Since 2013, highly effective, well-tolerated curative treatments have been available for hepatitis C, but no vaccine for preventing hepatitis C is yet available.The best way to prevent hepatitis C is by avoiding behaviors that can spread the disease, especially injecting drugs with non-sterile injection equipment.Hepatitis C in 2021Acute Hepatitis C5,023T here were 5,023 new cases of acute hepatitis C reported during 202 169,800There were 69,800 estimated acute hepatitis C virus infections during 202 1Chronic Hepatitis C107, 540T here were 107, 540 cases of newly reported chronic hepatitis C during 202 139.8There were 39.8 newly reported cases of chronic hepatitis C per 100,000 peopleAcute Hepatitis C in 2021The number of reported cases of acute hepatitis C has doubled since 201 4 (12 9 % increase), and during 202 1 increased 5% from 20 20 .There was a change to how public health defines a case of acute hepatitis C in 2020. This more sensitive and accurate definition helped capture cases that the less sensitive definition might have missed. This increase in cases detected due to the case definition change likely made up for any decreases that may have occurred due to the impact of the COVID-19 pandemic in 2020 and 2021.In 2020, CDC published universal adult and pregnancy screening guidelines. It is important that health care professionals , public health officials, and organizations involved in the development, implementation, delivery, and evaluation of clinical and preventive services follow and use these recommendations.Fast Facts About Acute Hepatitis C in 20212xThe number of acute hepatitis C case s has doubled since 201 4 , a 12 9 % increaseNon-Hispanic American Indian/Alaska NativeRates of acute hepatitis C are highest among non-Hispanic American Indian / Alaska Native persons20– 39Persons aged 20–39 years had the highest incidence of acute hepatitis C57%57% of cases with risk information reported injection drug useDuring 202 1 , rates of acute hepatitis C were highest among males, persons age d 20 – 39 years , non-Hispanic American Indian/Alaska Native (AI/AN) persons , and those living in the E astern and S outheastern states . Among cases with risk information reported, the most common was injection drug use .Chronic Hepatitis C in 2021During 2021, 43 states reported a total of 107,300 newly identified chronic hepatitis C cases in 2021, corresponding to 39.8 chronic hepatitis C cases per 100,000 people.Hepatitis C-associated deaths during 2021 decreased 8% (3.18 deaths per 100,000 people), compared to 2020 (3.45 deaths per 100,000 people).The age-adjusted death rate for hepatitis C during 2021 decreased 23% from 2017 (4.13 deaths per 100,000 people).The death rates were higher among non-Hispanic AI/AN and non-Hispanic Black persons (3.4 times and 1.7 times, respectively) than among non-Hispanic White persons.Fast Facts About Chronic Hepatitis C in 202165%During 202 1 , 6 5 % of newly reported chronic hepatitis C cases occurred among men66.9During 202 1 , the rate of newly reported chronic hepatitis C cases was highest among non-Hispanic AI/AN persons at 66. 9 cases per 100,000 p eopleChronic Hepatitis C affects multiple generations with infections highest among two age groups: 20–39 and 55–70 years.Hepatitis C Figures and Tables* Figure 3.1. Number of reported cases of acute hepatitis C virus infection and estimated infections — United States, 2014–2021* Figure 3.2. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2020–2021* Figure 3.3. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2021* Figure 3.4. Rates* of reported cases of acute hepatitis C virus infection, by age group — United States, 2006–2021* Figure 3.5. Rates of reported cases of acute hepatitis C virus infection, by sex — United States, 2006–2021* Figure 3.6. Rates of reported cases of acute hepatitis C virus infection, by race/ethnicity — United States, 2006–2021* Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2021* Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases by sex and age — United States, 2021* Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2021* Table 3.1. Numbers and rates of reported cases† of acute hepatitis C virus infection, by state or jurisdiction — United States, 2017–2021* Table 3.2. Numbers and rates of reported cases† of acute hepatitis C virus infection, by demographic characteristics — United States, 2017–2021* Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2021* Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2021* Table 3.5. Number and rate of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2021* Table 3.6. Number and rate of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2021* Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2017–2021* Table 3.8. Numbers and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2017–2021Last Reviewed: August 7, 2023Source: Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention* Syndicatehome Viral Hepatitis Surveillance – United States* 2022 Surveillance plus icon+ Overview plus icono Backgroundo National Profile of Viral Hepatitiso Technical Notes+ Hepatitis A plus icono Figure 1.1 – Number of Cases & Estimated Infectionso Figure 1.2 – Case Rates by Jurisdictiono Figure 1.3 – Map of Case Rateso Figure 1.4 – Case Rates by Age Groupo Figure 1.5 – Case Rates by Sexo Figure 1.6 – Case Rates by Race & Ethnicityo Figure 1.7 – Infection Risk Behaviorso Table 1.1 – Number & Rates of Cases by Jurisdictiono Table 1.2 – Cases & Rates by Demographicso Table 1.3 – Cases by Risk Behaviorso Table 1.4 – Death Rates by Demographics+ Hepatitis B plus icono Figure 2.1 – Acute – Number of Caseso Figure 2.2 – Acute – Case Rates by Jurisdictiono Figure 2.3 – Acute – Map of Case Rateso Figure 2.4 – Acute – Case Rates by Age Groupo Figure 2.5 – Acute – Case Rates by Sexo Figure 2.6 – Acute – Case Rates by Race & Ethnicityo Figure 2.7 – Acute – Infection Risko Figure 2.8 – Map of Death Rateso Table 2.1 – Acute – Number & Rates of Caseso Table 2.2 – Acute – Cases & Rates by Demographicso Table 2.3 – Acute – Cases by Risk Behaviorso Table 2.4 – Perinatal – Cases by Jurisdictiono Table 2.5 – Chronic – Case Rates by Jurisdictiono Table 2.6 – Chronic – Case Rates by Demographicso Table 2.7 – Death Rates by Jurisdictiono Table 2.8 – Death Rates by Demographics+ Hepatitis C plus icono Figure 3.1 – Acute – Number of Caseso Figure 3.2 – Acute – Case Rates by Jurisdictiono Figure 3.3 – Acute – Map of Case Rateso Figure 3.4 – Acute – Case Rates by Age Groupo Figure 3.5 – Acute – Case Rates by Sexo Figure 3.6 – Acute – Case Rates by Race & Ethnicityo Figure 3.7 – Acute – Infection Risk Behaviorso Figure 3.8 – Chronic – Case Rates by Sex & Ageo Figure 3.9 – Map of Death Rateso Table 3.1 – Acute – Number & Rates of Caseso Table 3.2 – Acute – Cases & Rates by Demographicso Table 3.3 – Acute – Infection Risk Behaviorso Table 3.4 – Perinatal – Cases by Jurisdictiono Table 3.5 – Chronic – Case Rates by Jurisdictiono Table 3.6 – Chronic – Case Rates by Demographicso Table 3.7 – Death Rates by Jurisdictiono Table 3.8 – Death Rates by Demographics+ Perinatal Hepatitis B Prevention Program plus icono Figure 4.1 – Outcomes by Birth Cohort Yearo Table 4.1 – Outcomes by Jurisdiction+ Appendix plus icono Figure 5.1 – Reported Acute Hepatitis B & C Caseso Table 5.1 – Acute Viral Hepatitis Caseso Table 5.2 – Acute & Chronic Hepatitis C Caseso Table 5.3 – Numbers & Rates of Reported Acute Hepatitis B & Co Figures & Tables – 2022 Viral Hepatitis Surveillance Report* 2021 Surveillance plus icon+ Overview plus icono Backgroundo National Profile of Viral Hepatitiso Technical Notes+ Hepatitis A plus icono Figure 1.1 – Number of Cases & Estimated Infectionso Figure 1.2 – Case Rates by Jurisdictiono Figure 1.3 – Map of Case Rateso Figure 1.4 – Case Rates by Age Groupo Figure 1.5 – Case Rates by Sexo Figure 1.6 – Case Rates by Race/Ethnicityo Figure 1.7 – Risk & Exposure Datao Table 1.1 – Number & Rates of Cases by Jurisdictiono Table 1.2 – Cases & Rates by Demographicso Table 1.3 – Risk & Exposure Datao Table 1.4 – Death Rates by Demographics+ Hepatitis B plus icono Figure 2.1 – Acute – Number of Cases & Estimated Infectionso Figure 2.2 – Acute – Case Rates by Jurisdictiono Figure 2.3 – Acute – Map of Case Rateso Figure 2.4 – Acute – Case Rates by Age Groupo Figure 2.5 – Acute – Case Rates by Sexo Figure 2.6 – Acute – Case Rates by Race/Ethnicityo Figure 2.7 – Acute – Risk & Exposureo Figure 2.8 – Map of Death Rateso Table 2.1 – Acute – Numbers & Rates of Caseso Table 2.2 – Acute – Cases & Rates by Demographicso Table 2.3 – Acute – Risk & Exposure Datao Table 2.4 – Perinatal – Cases by Jurisdictiono Table 2.5 – Chronic – Case Rates by Jurisdictiono Table 2.6 – Chronic – Case Rates by Demographicso Table 2.7 – Death Rates by Jurisdictiono Table 2.8 – Death Rates by Demographics+ Hepatitis C plus icono Figure 3.1 – Acute – Number of Cases & Estimated Infectionso Figure 3.2 – Acute – Case Rates by Jurisdictiono Figure 3.3 – Acute – Map of Case Rateso Figure 3.4 – Acute – Case Rates by Age Groupo Figure 3.5 – Acute – Case Rates by Sexo Figure 3.6 – Acute – Case Rates by Race/Ethnicityo Figure 3.7 – Acute – Risk & Exposure Datao Figure 3.8 – Chronic – Case Rates by Sex & Ageo Figure 3.9 – Map of Death Rateso Table 3.1 – Acute – Number & Rates of Caseso Table 3.2 – Acute – Cases & Rates by Demographicso Table 3.3 – Acute – Risk & Exposure Datao Table 3.4 – Perinatal – Cases by Jurisdictiono Table 3.5 – Chronic – Case Rates by Jurisdictiono Table 3.6 – Chronic – Case Rates by Demographicso Table 3.7 – Death Rates by Jurisdictiono Table 3.8 – Death Rates by Demographics+ Perinatal Hepatitis B Prevention Program plus icono Figure 4.1 – Outcomes by Birth Cohort Yearo Table 4.1 – Outcomes by Jurisdiction+ Appendix plus icono Figure 5.1 – Number of Cases & Estimated Infections for 18–40 Yearso Table 5.1 – Reported Cases & Estimated Infections – 95% CIo Table 5.2 – Acute & Chronic Hepatitis C Cases Confirmed and Probableo Table 5.3 – Hepatitis B & C for 18–40 Yearso Tables & Figures – 2021 Viral Hepatitis Surveillance Report* 2020 Surveillance plus icon+ Overview plus icono Backgroundo National Profile of Viral Hepatitiso Technical Notes+ Hepatitis A plus icono Figure 1.1 – Number of Cases & Estimated Infectionso Figure 1.2 – Case Rates by Jurisdictiono Figure 1.3 – Map of Case Rateso Figure 1.4 – Case Rates by Age Groupo Figure 1.5 – Case Rates by Sexo Figure 1.6 – Case Rates by Race & Ethnicityo Figure 1.7 – Risk & Exposure Datao Table 1.1 – Number & Rates of Cases by Jurisdictiono Table 1.2 – Cases & Rates by Demographicso Table 1.3 – Risk & Exposure Datao Table 1.4 – Death Rates by Demographics+ Hepatitis B plus icono Figure 2.1 – Acute – Number of Cases & Estimated Infectionso Figure 2.2 – Acute – Case Rates by Jurisdictiono Figure 2.3 – Acute – Map of Case Rateso Figure 2.4 – Acute – Case Rates by Age Groupo Figure 2.5 – Acute – Case Rates by Sexo Figure 2.6 – Acute – Case Rates by Race & Ethnicityo Figure 2.7 – Acute – Risk & Exposureo Figure 2.8 – Map of Death Rateso Table 2.1 – Acute – Number & Rates of Caseso Table 2.2 – Acute – Cases & Rates by Demographicso Table 2.3 – Acute – Risk & Exposure Datao Table 2.4 – Perinatal – Cases by Jurisdictiono Table 2.5 – Chronic – Case Rates by Jurisdictiono Table 2.6 – Chronic – Case Rates by Demographicso Table 2.7 – Death Rates by Jurisdictiono Table 2.8 – Death Rates by Demographics+ Hepatitis C plus icono Figure 3.1 – Acute – Number of Cases & Estimated Infectionso Figure 3.2 – Acute – Case Rates by Jurisdictiono Figure 3.3 – Acute – Map of Case Rateso Figure 3.4 – Acute – Case Rates by Age Groupo Figure 3.5 – Acute – Case Rates by Sexo Figure 3.6 – Acute – Case Rates by Race & Ethnicityo Figure 3.7 – Acute – Risk & Exposure Datao Figure 3.8 – Chronic – Case Rates by Sex & Ageo Figure 3.9 – Map of Death Rateso Table 3.1 – Acute – Number & Rates of Caseso Table 3.2 – Acute – Cases & Rates by Demographicso Table 3.3 – Acute – Risk & Exposure Datao Table 3.4 – Perinatal – Cases by Jurisdictiono Table 3.5 – Chronic – Case Rates by Jurisdictiono Table 3.6 – Chronic – Case Rates by Demographicso Table 3.7 – Death Rates by Jurisdictiono Table 3.8 – Death Rates by Demographics+ Perinatal Hepatitis B Prevention Program plus icono Figure 4.1 – Outcomes by Birth Cohort Yearo Table 4.1 – Outcomes by Jurisdiction+ Appendix plus icono Figure 5.1 – Hepatitis B & C Rates 18-40 yearso Table 5.1 – Estimated infections and 95% CIo Table 5.2 – Acute & Chronic Hepatitis C Cases Confirmed and Probableo Table 5.3 – Hepatitis B & C Rates 18-40 yearso Tables & Figures | 2020 Viral Hepatitis Surveillance Report* 2019 Surveillance plus icon+ Introduction+ Hepatitis A plus icono Figure 1.1o Figure 1.2o Figure 1.3o Figure 1.4o Figure 1.5o Figure 1.6o Figure 1.7o Table 1.1o Table 1.2o Table 1.3o Table 1.4+ Hepatitis B plus icono Figure 2.1o Figure 2.2o Figure 2.3o Figure 2.4o Figure 2.5o Figure 2.6o Figure 2.7o Figure 2.8o Table 2.1o Table 2.2o Table 2.3o Table 2.4o Table 2.5o Table 2.6o Table 2.7o Table 2.8+ Hepatitis C plus icono Figure 3.1o Figure 3.2o Figure 3.3o Figure 3.4o Figure 3.5o Figure 3.6o Figure 3.7o Figure 3.8o Figure 3.9o Table 3.1o Table 3.2o Table 3.3o Table 3.4o Table 3.5o Table 3.6o Table 3.7o Table 3.8+ Appendix+ Supplemental Report* 2018 Surveillance plus icon+ Introduction+ Hepatitis A+ Hepatitis B+ Hepatitis C+ Appendix* 2017 Surveillance plus icon+ Hepatitis A Tables and Figures+ Hepatitis B Tables and Figures+ Hepatitis C Tables and Figures* 2016 Surveillance plus icon+ Commentary+ Table 1.1 Hepatitis C Outbreaks* 2015 Surveillance plus icon+ Commentary+ Table 1.1 Hepatitis C Outbreaks* 2014 Surveillance plus icon+ Commentary* 2013 Surveillance plus icon+ Commentary plus icono Erratum* 2012 Surveillance plus icon+ Commentary* 2011 Surveillance plus icon+ Commentary* 2010 Surveillance plus icon+ Commentary* 2009 Surveillance plus icon+ Commentary* 2008 Surveillance plus icon+ CommentaryHepatitis AHepatitis BHepatitis CHepatitis DHepatitis ECOVID-19 InformationViral Hepatitis Home* Overview of Viral Hepatitis* Statistics & Surveillance* Populations & Settings* Outbreaks* State and Local Partners & Grantees* Policy, Programs, and Science* Resource Center* Global* About CDC* Contact Us* 800-232-4636Facebook Twitter Instagram LinkedIn Youtube Pinterest SnapchatFacebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat RSS* CONTACT CDCContact UsCall 800-232-4636Email Us* ABOUT CDC+ About CDC+ Jobs+ Funding* POLICIES+ Accessibility+ External Links+ Privacy+ Policies+ Web Policies+ No Fear Act+ FOIA+ OIG+ No Fear Act+ Nondiscrimination+ Vulnerability Disclosure Policy+ CDC Archive+ Public Health Publications+ HHS.gov+ USA.gov* CONNECT WITH US+ Youtube+ Snapchat* LANGUAGES+ Español+ 繁體中文+ Tiếng Việt+ 한국어+ Tagalog+ Русский+ العربية+ Kreyòl Ayisyen+ Français+ Polski+ Português+ Italiano+ Deutsch+ 日本語+ فارسی+ English* U.S. Department of Health & Human Services* Accessibility* External Links* Privacy* Policies* Web Policies* FOIA* OIG* No Fear Act* FOIA* Nondiscrimination* OIG* Vulnerability Disclosure Policy* CDC Archive* Public Health Publications* HHS.gov* USA.govContent Credential×This image was edited or created using GenAI (generative artificial intelligence).Our experts review all images in an effort to ensure accuracy and quality before use.Learn more about CDC's usage of GenAI.
Note: Comparison ignores leading/trailing whitespace
and certain script/tracking codes. Word-level
highlighting (optional above) only applies to changed
lines.